The morbidity and mortality of stroke may be lowered considerably by instituting preventive interventions for patients at risk. A number of important clinical trials have compared the use of novel agents (dabigatran, rivaroxaban, and apixaban) with standard anticoagulant therapy to prevent stroke and ...
In a majotity of cases, strokes entails minor or major level of disability. Only in a small percentage of patients, the treatment results in complete regression of neurologic deficit. After stroke, patients must learn to live with an arrey of restrictions in various fields of life, which is ...
Stroke is the second leading cause of death worldwide; however, the treatment choices available to neurologists are limited in clinical practice. Lipocalin 2 (LCN2) is a secreted protein, belonging to the lipocalin superfamily, with multiple biological functions in mediating innate immune response, ...
The role of neurologists in the treatment of older patients with epilepsy Epilepsy is a common disease in the elderly. About 1.5% of elderly individuals are thought to suffer from epilepsy; however, the medical system is insuffic... T Tanaka - 《Neurological Therapeutics》 被引量: 0发表: 202...
Of note, MS was initially identified by Jean-Martin Charcot, a French neurologist, in 1868, who described multiple scars in the brain and spinal cord [8]. To better understand the MS pathophysiology, we focused on the lipids that play an influential role in the disease background. Lipids ...
Persistence of increased neuron numbers under cognitive challenge Next, an experiment was designed to explore the old neurologists' rule, 'use-it-or-lose-it'. Starting at week 4 (time point 0 in Figure 1a), mice were for 22 weeks either exposed to long-term standard housing without ...
In 1995 the EFNS has made stroke treatment and prevention a major policy issue and established a Task Force to develop guidelines for acute neurological stroke care for use by neurologists throughout Europe and to be modified according t... M Brainin - 《European Journal of Neurology》 被引...
[7]. Of note, MS was initially identified by Jean-Martin Charcot, a French neurologist, in 1868, who described multiple scars in the brain and spinal cord [8]. To better understand the MS pathophysiology, we focused on the lipids that play an influential role in the disease background. ...
Melatonin treatment showed a potent neuroprotective action in experimental models and in clinical studies. However, the entire disease prevention is not ob
American Heart Association: 2004 heart and stroke statistical update. Available at http://www.Americanheart.Org/statistics/index.html. Accessed November 2004. Sanossian N, Ovbiagele B: Multimodality stroke prevention. Neurologist 2006, 12:14–31. Article PubMed Google Scholar Cholesterol, diastolic...